MedCap AB (publ) (STO:MCAP)

Market Cap	8.33B -10.1%
Revenue (ttm)	2.26B +18.6%
Net Income	240.60M +21.1%
EPS	16.07 +20.8%
Shares Out	14.98M
PE Ratio	34.64
Forward PE	25.17
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,868
Open	554.50
Previous Close	549.00
Day's Range	546.50 - 560.50
52-Week Range	440.00 - 677.00
Beta	0.49
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 21, 2026

About MedCap AB

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products; and Assistive Tech including digital and physical solutions in cognition, communication, environmental control, alarms, mobility, accessibility, and orth...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 637
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MCAP

Financial Performance

In 2025, MedCap AB's revenue was 2.11 billion, an increase of 16.73% compared to the previous year's 1.81 billion. Earnings were 219.80 million, an increase of 5.98%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 24, 2026

Data Sources Report a data error